Assessing Immunotherapy Efficacy in Syngeneic Models with Our NanoString Service

The PanCancer Immune Profiling and the PanCancer IO 360 panels are novel tools engineered specifically for syngeneic Immuno-Oncology studies.  With Canopy’s Immuno-Oncology service, researchers that were once limited  by sample type and low throughput technology  are now able to conduct high throughput robust analysis with a wide variety of  sample types including FFPE tissue.  Additionally, Canopy Biosciences provides a comprehensive data analysis package formatted for easy interpretation of immunotherapeutic efficacy data from your syngeneic study.

Canopy Biosciences Immuno-Oncology Offering:

  • Does NOT require live cells
  • Can conduct immune cell abundance scoring
  • Uses minimal sample input (fresh or fixed tissue, cells, blood, serum, plasma, or PBMC’s)
  • Can assess mechanistic pathway activity for single or combination studies
  • Delivers a Comprehensive Data Analysis Package


HOW CAN CANOPY BIOSCIENCES STREAMLINE YOUR SYNGENEIC IMMUNOTHERAPY EFFICACY STUDY?

Simply complete this form to download our white paper entitled: Syngeneic Preclinical Efficacy Studies Streamlined with Canopy Biosciences







0

Start typing and press Enter to search